BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32561830)

  • 21. Ackr3-Venus knock-in mouse lights up brain vasculature.
    Ehrlich AT; Semache M; Couvineau P; Wojcik S; Kobayashi H; Thelen M; Gross F; Hogue M; Le Gouill C; Darcq E; Bouvier M; Kieffer BL
    Mol Brain; 2021 Sep; 14(1):151. PubMed ID: 34583741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
    Silwedel C; Speer CP; Haarmann A; Fehrholz M; Claus H; Buttmann M; Glaser K
    J Neuroinflammation; 2018 May; 15(1):156. PubMed ID: 29792190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7.
    Meyrath M; Palmer CB; Reynders N; Vanderplasschen A; Ollert M; Bouvier M; Szpakowska M; Chevigné A
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):813-823. PubMed ID: 33860204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of ligand interaction with atypical chemokine receptor 3.
    Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
    Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulators of CXCR4 and CXCR7/ACKR3 Function.
    Adlere I; Caspar B; Arimont M; Dekkers S; Visser K; Stuijt J; de Graaf C; Stocks M; Kellam B; Briddon S; Wijtmans M; de Esch I; Hill S; Leurs R
    Mol Pharmacol; 2019 Dec; 96(6):737-752. PubMed ID: 31548340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle.
    Albee LJ; LaPorte HM; Gao X; Eby JM; Cheng YH; Nevins AM; Volkman BF; Gaponenko V; Majetschak M
    Open Biol; 2018 Jan; 8(1):. PubMed ID: 29386406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis.
    Yang J; Miao RR; Li YN; Pan T; Wu SH; Qu XJ; Cui SX
    Acta Pharmacol Sin; 2022 Nov; 43(11):2967-2976. PubMed ID: 35365782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells.
    Sigmund EC; Bauer A; Jakobs BD; Tatliadim H; Tacconi C; Thelen M; Legler DF; Halin C
    PLoS One; 2023; 18(5):e0285597. PubMed ID: 37252916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
    Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
    Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface.
    Quinn KE; Matson BC; Caron KM
    Placenta; 2020 Jun; 95():18-25. PubMed ID: 32452398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
    Szpakowska M; D'Uonnolo G; Luís R; Alonso Bartolomé A; Thelen M; Legler DF; Chevigné A
    Front Immunol; 2023; 14():1133394. PubMed ID: 37153591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
    Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
    J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function.
    Smit MJ; van Muijlwijk-Koezen JE
    Mol Pharmacol; 2019 Dec; 96(6):735-736. PubMed ID: 31624136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Small Molecule Ligands on ACKR3 Receptors.
    Hopkins BE; Masuho I; Ren D; Iyamu ID; Lv W; Malik N; Martemyanov KA; Schiltz GE; Miller RJ
    Mol Pharmacol; 2022 Sep; 102(3):128-138. PubMed ID: 35809897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
    Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
    Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.
    Tobia C; Chiodelli P; Barbieri A; Buraschi S; Ferrari E; Mitola S; Borsani G; Guerra J; Presta M
    Front Immunol; 2019; 10():1092. PubMed ID: 31156639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
    Fumagalli A; Zarca A; Neves M; Caspar B; Hill SJ; Mayor F; Smit MJ; Marin P
    Mol Pharmacol; 2019 Dec; 96(6):794-808. PubMed ID: 30837297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation.
    Cebo M; Dittrich K; Fu X; Manke MC; Emschermann F; Rheinlaender J; von Eysmondt H; Ferreirós N; Sudman J; Witte A; Pelzl L; Borst O; Geisler T; Rath D; Bakchoul T; Gawaz M; Schäffer TE; Lämmerhofer M; Chatterjee M
    Blood; 2022 Mar; 139(11):1722-1742. PubMed ID: 34905596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.